NOVEL REGIMES OF FXR AGONISTS

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

Bryan LAFFITTE,Andreas BAUER,Michael BADMAN,Jin CHEN,Patrick MUELLER,Rachel SOON

申请号：

US16333030

公开号：

US20190262313A1

申请日:

2017.09.12

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The invention provides novel regimens of farnesoid X receptor (FXR) agonist and methods for modulating the activity of farnesoid X receptors (FXRs) using novel regimes of specific FXR agonists, in particular for treating or preventing fibrotic or cirrhotic diseases or disorders, such as liver diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/